Feng Xie - McMaster Experts

Affiliations

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Contact
View All

selected scholarly activity

chapters
- Economic Evaluations in Surgery. 239-253. 2019
- Clinical Decision Analysis. 13-22. 2018
conferences
- Clinical utility of artificial intelligence-augmented endobronchial ultrasound elastography in lymph node staging for lung cancer.. JTCVS Tech. 158-166. 2024
- 142 Values and preferences towards the use of prophylactic low-molecular- weight heparin during pregnancy: a convergent mixed-methods analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study. ISDM Conference – AMH Randomised Trial Abstract. a65-a65. 2024
- Detection of bladder cancer relapse after TURBT through urinary tumor DNA analysis: A prospective real-world evidence study. Journal of Clinical Oncology. 2023
- Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC). Journal of Clinical Oncology. 2023
- Ultra-sensitive baseline-informed MRD assay to predict prognosis outcomes in patients with resectable hepatocellular carcinoma.. Journal of Clinical Oncology. 2023
- Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. A15. TAKING PULMONARY REHABILITATION TO THE NEXT LEVEL. a1021-a1021. 2023
- Development and clinical application of PredicineBEACON next-generation minimal residual disease assay for genitourinary cancers.. Journal of Clinical Oncology. 2022
- Longitudinal personalized urinary tumor DNA analysis in muscle-invasive bladder cancer from the neoadjuvant immunotherapy trial RJBLC-I2N003.. Journal of Clinical Oncology. 2022
- IDDF2021-ABS-0025 Discriminating endoscopic features of sessile serrated lesions: a systematic review and meta-analysis. Gut. A96-A97. 2021
- Health-related quality of life in the treatment and survivorship phases of breast cancer.. Journal of Clinical Oncology. e18621-e18621. 2021
- P0554 / #1652: LIBERATION FROM PICU-ACQUIRED COMPLICATIONS: BI-CENTER IMPLEMENTATION STUDY. Pediatric Critical Care Medicine. 276-276. 2021
- Circulating tumor DNA analysis of genomic alterations in metastatic urothelial carcinoma from NCT03113266 study.. Journal of Clinical Oncology. 2021
- Superior molecular pathology of urothelial bladder cancer using urinary cell-free DNA.. Journal of Clinical Oncology. 2021
- The effect of computer decision support on optimizing appropriate dosing of novel oral anticoagulant therapy in the IMPACT-AF study. European Heart Journal. 642-642. 2020
- Cell-free DNA comparative analysis of hormone receptor-positive, first-line metastatic breast cancer genomic landscape in the United States and China.. Journal of Clinical Oncology. 2020
- The characterization of IDH1 mutations in Chinese biliary tract cancers.. Journal of Clinical Oncology. 2020
- Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2020
- 1230: LIBERATION FROM PICU-ACQUIRED COMPLICATIONS: A BI-CENTER IMPLEMENTATION STUDY. Critical Care Medicine. 592-592. 2020
- PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY. Value in Health. S63-S63. 2019
- PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING. Value in Health. S63-S64. 2019
- PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. Value in Health. S300-S301. 2019
- CE3 - COST-EFFECTIVENESS OF DEMENTIA CARE MANAGEMENT ALONGSIDE A CLUSTER-RANDOMIZED CONTROLLED INTERVENTIONAL DELPHI TRIAL. Value in Health. S3-S3. 2018
- PRM68 - IMPUTATION METHODS FOR MISSING DATA IN COST-UTILITY ANALYSES ALONGSIDE RANDOMIZED CONTROLLED TRIALS: AGGREGATE OR NON-AGGREGATE?. Value in Health. S366-S367. 2018
- United States Valuation of EQ-5D-5L Health States: An Initial Model Using a Standardized Protocol. Value in Health. S4-S5. 2018
- Association between progression-free survival and health-related quality of life in oncology: A systematic review and regression analysis.. Journal of Clinical Oncology. 6574-6574. 2017
- ROBOTIC-ASSISTED THORACOSCOPIC PULMONARY RESECTION VERSUS VIDEO-ASSISTED THORACOSCOPIC PULMONARY RESECTION FOR EARLY STAGE NON-SMALL CELL LUNG CANCER: A HEALTHCARE UTILIZATION ANALYSIS. Value in Health. A105-A105. 2017
- Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Quality of Life Research. 132-132. 2016
- Health literacy and logical inconsistencies in valuations of hypothetical health states: data from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 24-25. 2016
- A time trade-off-derived value set of the 5-level EQ-5D for Canada. Quality of Life Research. 53-54. 2015
- Determinants of health preferences in the Canadian EQ-5D-5L Valuation Study. Quality of Life Research. 177-178. 2015
- Instrument-defined estimates of minimally important difference in EQ-5D-5L index score for Canadian, Chinese and Spanish scoring algorithms. Quality of Life Research. 181-181. 2015
- EQ-5D health utilities are estimated subject to considerable uncertainty. Value in Health. A195-A195. 2014
- The Canadian Eq-5d Valuation Study: Estimating Time Trade-Off Values For The Eq-5d-5l. Value in Health. A163-A163. 2014
- Use Of Economic Evidence To Inform Drug Reimbursement Decision Making: The Case For Ontario. Value in Health. A18-A18. 2014
- Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D. Value in Health. A326-A326. 2013
- The EQ-5D-5L international protocol and the Canadian experience. Quality of Life Research. 2013
- Are canadians different from americans in stated preferences for health? valuing EQ-5D-5L health states using discrete choice experiments. Value in Health. A32-A32. 2013
- COMPARING EQ-5D VALUATION STUDIES: A SYSTEMATIC REVIEW AND METHODOLOGICAL REPORTING CHECKLIST. Value in Health. A45-A45. 2013
- HEALTH UTILITIES INDEX (R) : EXTENDING THE AGE RANGE TO PRE-SCHOOLERS. Value in Health. A36-A36. 2013
- Valuing EQ-5D-5L: Can latent utilities derived from a discrete choice model be transformed to health utilities derived from time trade-off tasks?. Value in Health. A31-A31. 2013
- CHARACTERISTICS OF THE ABORIGINAL PEOPLE WITH DIABETES IN THE SOUTH-WESTERN OF ONTARIO, CANADA. Value in Health. A495-A496. 2012
- PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada. Value in Health. A499-A499. 2012
- PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada. Value in Health. A507-A507. 2012
- PRM6 Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis. Value in Health. A646-A646. 2012
- Evidence from four countries on the validity of the discrete choice model in quantifying health-states for the new EQ-5D-5L. Quality of Life Research. 12-12. 2012
- PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling. Value in Health. A198-A199. 2012
- PCN127 Health State Utility Assessment for Breast Cancer. Value in Health. A457-A457. 2011
- PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies. Value in Health. A260-A260. 2011
- PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS. Value in Health. A119-A120. 2011
- PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS. Value in Health. A83-A83. 2011
- PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS. Value in Health. A150-A151. 2011
- A New Practicable GLLH EM Invisible Cloak without Exceeding Light Speed Wave. Progress in Electromagnetics Research Symposium. 18-26. 2011
- HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. A133-A133. 2010
- PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHN'S DISEASE. Value in Health. A73-A73. 2010
- PMS74 USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX. Value in Health. A136-A136. 2010
- PRS7 TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Value in Health. A197-A197. 2010
- UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO. Value in Health. A133-A134. 2010
- 3D GL EMFH Modeling and Inversion for Leak less Auto EMS in Steel Metal Casting and Biomedical EM Instruments Design. Progress in Electromagnetics Research Symposium. 268-273. 2010
- A Novel GL Double Layer Electromagnetic Cloaks in Broad Frequency Band and Reciprocal Law. Progress in Electromagnetics Research Symposium. 623-630. 2010
- Massively Parallel Constraint Programming for Supercomputers: Challenges and Initial Results. Lecture Notes in Computer Science. 334-+. 2010
- DB1 USING POPULATION-BASED ESTIMATES FOR DISEASE MODELING: POTENTIAL BIAS COMPARED TO USING DISEASE-SPECIFIC DEATH AND COMPLICATION RISK ESTIMATES. Value in Health. A234-A234. 2009
- PDB21 WHO ARE THEY FOOLING?: COST OF DISEASE OR COMPLICATIONS CAN SIGNIFICANTLY BIAS ESTIMATES UNLESS CONTROL (NON-DISEASED) COSTS ARE NOT ALSO ACCOUNTED FOR IN THE ANALYSIS. Value in Health. A405-A405. 2009
- PG14 SYSTEMATIC REVIEW: THE CLINICAL EFFECTIVENESS OF ANTI-TNFALPHA DRUGS IN ADULTS WITH REFRACTORY CROHN'S DISEASE. Value in Health. A346-A346. 2009
- PHP80 CLINICAL EFFECTIVENESS OF PORTABLE ULTRASOUND IN SMALL EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW. Value in Health. A252-A252. 2009
- PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP. Value in Health. A374-A374. 2009
- PSY18 THE BURDEN OF OBESITY IN ONTARIO. Value in Health. A378-A378. 2009
- PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA. Value in Health. A380-A381. 2009
- PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI-TNF-ALPHA; DRUGS FOR REFRACTORY ULCERATIVE COLITIS. Value in Health. A58-A58. 2009
- PMS45 EXTENSION FROM INPATIENTS TO OUTPATIENTS: PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS. Value in Health. A72-A72. 2009
- PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO. Value in Health. A131-A131. 2009
- QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA. Value in Health. A17-A17. 2009
- 3D AGILD Mechanical Modeling for Simulations of New Materials. PIERS 2009 MOSCOW VOLS I AND II, PROCEEDINGS. 958-+. 2009
- GL TM Dielectric Parameter Inversion. Progress in Electromagnetics Research Symposium. 747-752. 2009
- Global and Local Field EM Modeling and Novel GL Double Layered Electromagnetic Cloaks. PIERS 2009 MOSCOW VOLS I AND II, PROCEEDINGS. 335-343. 2009
- No Maxwell Electromagnetic Wavefield Excited inside Cloaked Concealment and Broadband GL Cloaks. PIERS 2009 MOSCOW VOLS I AND II, PROCEEDINGS. 66-72. 2009
- PGI7 COST EFFECTIVENESS ANALYSIS OF HELICOBACTER PYLORI SCREENING IN PREVENTION OF GASTRIC CANCER IN CHINESE. Value in Health. A85-A86. 2008
- PMS34 ATWO-YEAR EVALUATION OF HEALTH OUTCOMES IN OSTEOARTHRITIS PATIENTS AFTERTOTAL KNEE REPLACEMENT. Value in Health. A265-A265. 2008
- Canards in a Model of Morphogenetic Process. PROCEEDINGS OF THE 6TH CONFERENCE OF BIOMATHEMATICS, VOLS I AND II. 135-138. 2008
- GL Acoustic Mechanical and EM uniform coupled modeling and inversion. Progress in Electromagnetics Research Symposium. 52-59. 2008
- PAR32 INVESTIGATION OF RESPONSE SHIFT IN HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS UNDERGOINGTOTAL KNEE REPLACEMENT. Value in Health. A253-A253. 2007
- PND27 DETECTION OF DIFFERENTIAL ITEM FUNCTIONING BETWEEN ENGLISH AND CHINESE VERSIONS OF THE PDQ-8. Value in Health. A94-A95. 2007
- PAR11 ARE THEY MEASURABLE? A STUDY ON ELICITING INDIRECT AND INTANGIBLE COSTS OF KNEE OSTEOARTHRITIS USING HUMAN CAPITAL APPROACH AND WILLINGNESS-TO-PAY IN MULTIETHNIC ASIAN POPULATION IN SINGAPORE. Value in Health. A223-A223. 2006
- PMC13 APPLYING EXPECTANCY-VALUE MODEL TO UNDERSTAND HEALTH PREFERENCE-AN EXPLORATORY STUDY. Value in Health. A59-A60. 2006
- Optimizing caching policy for loss recovery in reliable multicast. IEEE Infocom. Proceedings. 568-579. 2006
- LINKING IMPORTANT HEALTH-RELATED QUALITY OF LIFE ITEMS WITH THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH FROM PERSPECTIVE OF PATIENTS WITH KNEE OSTEOARTHRITIS: CRITICAL EVALUATION OF THE ICF CORE SETS FOR OSTEOARTHRITIS. Quality of Life Research. 2085-2085. 2005
- PAR10 ARE THEY RELEVANT? A CRITICAL EVALUATION OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH CORE SETS FOR OSTEOARTHRITIS FROM THE PERSPECTIVE OF PATIENTS WITH KNEE OSTEOARTHRITIS IN SINGAPORE. Value in Health. A27-A27. 2005
- WHICH DOMAINS OF HEALTH-RELATED QUALITY OF LIFE ARE IMPORTANT IN HIP AND KNEE OSTEOARTHRITIS? A QUALITATIVE SYSTEMATIC LITERATURE REVIEW. Quality of Life Research. 1593-1593. 2004
- PCN22 THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE CORE QUESTIONNAIRE (EORTC QLQ-C30): VALIDATION OF ENGLISH VERSION IN SINGAPORE. Value in Health. 252-252. 2004
journal articles
- Osteochondroplasty with or without labral repair is more cost-effective than arthroscopic lavage with or without labral repair for treatment of young adults with femoroacetabular impingement: A cost-utility analysis based on data from a randomized controlled trial.. Journal of ISAKOS. 9:100307. 2024
- Health utilities used in oncology cost-utility analyses: a registry-based analysis.. Quality of Life Research. 1-7. 2024
- Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure.. European Journal of Heart Failure. 2024
- Systematic methodological review of health state values in glaucoma cost-utility analyses. European Journal of Health Economics. 25:1417-1435. 2024
- A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments: Part II Psychometric Properties.. Value in Health. S1098-3015(24)06692-0. 2024
- Economic burden of patients with leading cancers in China: a cost-of-illness study.. BMC Health Services Research. 24:1135. 2024
- Artificial Intelligence Algorithm Can Predict Lymph Node Malignancy from Endobronchial Ultrasound Transbronchial Needle Aspiration Images for Non-Small Cell Lung Cancer.. Respiration; international review of thoracic diseases. 1-11. 2024
- Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study.. Thrombosis Journal. 22:81. 2024
- Economic evaluation of the “paramedics and palliative care: bringing vital services to Canadians” program compared to the status quo. Canadian Journal of Emergency Medicine. 26:671-680. 2024
- Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.. European Heart Journal Open. 4:oeae083. 2024
- Validation of the Generic Version of China Health Related Outcomes Measures (CHROME-G) among individuals with type 2 diabetes in China.. Journal of Evidence-Based Medicine. 17:615-625. 2024
- A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity. Value in Health. 27:1130-1148. 2024
- Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L. Value in Health. 27:1092-1099. 2024
- Vanishing viscosity limit of compressible viscoelastic equations in half space. Journal of Differential Equations. 398:319-343. 2024
- Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation. New England Journal of Medicine. 391:9-20. 2024
- Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care. JAMA network open. 7:e2419282-e2419282. 2024
- Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial. American Heart Journal. 273:102-110. 2024
- ROBVALU: a tool for assessing risk of bias in studies about people’s values, utilities, or importance of health outcomes. The BMJ. 385:e079890-e079890. 2024
- Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses. Value in Health. 27:706-712. 2024
- Health state utility assessment for low-grade glioma.. Journal of Clinical Oncology. 42:e14039-e14039. 2024
- Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L. Cerebellum. 23:1020-1030. 2024
- PCR180 Measuring and Valuing Child Health in Canada. Value in Health. 27:s329. 2024
- Protocol implementation during the COVID-19 pandemic: experiences from a randomized trial of stress ulcer prophylaxis. BMC Medical Research Methodology. 24:109. 2024
- Creating a Multiply Imputed Value Set for the EQ-5D-5L in Canada: State-Level Misspecification Terms Are Needed to Characterize Parameter Uncertainty Correctly. Medical decision making. 44:405-414. 2024
- Understanding Canadian stakeholders’ views on measuring and valuing health for children and adolescents: a qualitative study. Quality of Life Research. 33:1415-1422. 2024
- LONG TIME WELL-POSEDNESS OF COMPRESSIBLE MAGNETOHYDRODYNAMIC BOUNDARY LAYER EQUATIONS IN SOBOLEV SPACES. Discrete and Continuous Dynamical Systems. Series A. 44:943-969. 2024
- Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial. Transfusion. 64:606-614. 2024
- Validation of China Health-Related Outcomes Measures-Cardiovascular Disease. Value in Health. 27:490-499. 2024
- Scoring the Value Assessment Framework for China: A Factorial Survey. Value in Health. 27:330-339. 2024
- Canada population norms for the EQ-5D-5L. European Journal of Health Economics. 25:147-155. 2024
- Early Rehabilitation in Critically ill Children: A Two Center Implementation Study*. Pediatric Critical Care Medicine. 25:92-105. 2024
- A 12-month follow-up study of discharged patients with acute pancreatitis: An acute condition with prolonged sequela.. National Medical Journal of China. 137:250-252. 2024
- Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis. PharmacoEconomics (Auckland). 42:41-68. 2024
- Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis. PharmacoEconomics (Auckland). 42:41-68. 2024
- Effectiveness of a Meta-Cognitive Group Intervention for Older Adults with Subjective Cognitive Decline or Mild Cognitive Impairment: The ASPIRE Randomized Controlled Trial.. Journal of Prevention of Alzheimer's Disease. 11:1534-1548. 2024
- GLOBAL EXISTENCE AND ASYMPTOTIC BEHAVIOR OF THE FULL EULER SYSTEM WITH DAMPING AND RADIATIVE EFFECTS IN R³. Communications in Mathematical Sciences. 22:789-816. 2024
- One-Day Peer-Delivered Cognitive Behavioral Therapy-Based Workshops for Postpartum Depression: A Randomized Controlled Trial. Psychotherapy and Psychosomatics. 93:129-140. 2024
- REVISE: re-evaluating the inhibition of stress erosions in the ICU—statistical analysis plan for a randomized trial. Trials. 24:796. 2023
- Identifying factors associated with high use of acute care in Canada: a population-based retrospective study. European Journal of Health Economics. 24:1505-1515. 2023
- Robotic Lobectomy Is Cost-effective and Provides Comparable Health Utility Scores to Video-assisted Lobectomy. Annals of Surgery. 278:841-849. 2023
- Differences between physician and patient preferences for cancer treatments: a systematic review. BMC Cancer. 23:1126. 2023
- Assessment of a venous thromboembolism prophylaxis shared decision-making intervention (DASH-TOP) using the decisional conflict scale: a mixed-method study. BMC Medical Informatics and Decision Making. 23:250. 2023
- Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies. PharmacoEconomics (Auckland). 41:1453-1467. 2023
- REVISE:Re-Evaluating theInhibition ofStressErosions in the ICU: a randomised trial protocol. BMJ Open. 13:e075588-e075588. 2023
- Resource use and cost associated with computerized decision support system and usual care in managing patients with atrial fibrillation: analysis of IMPACT-AF randomized trial data. BMC Medical Informatics and Decision Making. 23:228. 2023
- Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study. BMJ Evidence-Based Medicine. 28:309-319. 2023
- GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations. Journal of Clinical Epidemiology. 162:135-144. 2023
- In-person 1-day cognitive behavioral therapy-based workshops for postpartum depression: a randomized controlled trial. Psychological Medicine. 53:6888-6898. 2023
- Relaxation oscillations of a piecewise-smooth slow-fast Bazykin's model with Holling type Ⅰ functional response.. Mathematical Biosciences and Engineering. 20:17608-17624. 2023
- Large time behavior of solutions to a diffusion approximation radiation hydrodynamics model. Journal of Differential Equations. 366:518-564. 2023
- China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population. Quality of Life Research. 32:2463-2476. 2023
- Remarks on Sharp Interface Limit for an Incompressible Navier-Stokes and Allen-Cahn Coupled System. Chinese Annals of Mathematics. Series B. 44:663-686. 2023
- Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation. Value in Health. 26:1405-1412. 2023
- Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app. BMJ Open. 13:e075736-e075736. 2023
- Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma. Value in Health. 26:1249-1257. 2023
- Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets. Medical decision making. 43:587-594. 2023
- Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease. European Journal of Preventive Cardiology (EJPC). 30:535-545. 2023
- Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective. Current Oncology. 30:4688-4699. 2023
- Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion. CMAJ open. 11:E443-E450. 2023
- Darboux integrability of a Mathieu-van der Pol-Duffing oscillator. Nonlinear Analysis: Real World Applications. 70. 2023
- Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study. PharmacoEconomics (Auckland). 41:439-455. 2023
- Sponsorship bias in oncology cost effectiveness analysis. Journal of Clinical Epidemiology. 156:22-29. 2023
- Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis. Journal of Hematology and Oncology. 16:19. 2023
- Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis. Clinical Lymphoma, Myeloma and Leukemia. 23:127-137. 2023
- Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties. Value in Health. 26:251-260. 2023
- Fluctuations of health states in dementia diseases and their impact on the assessment of health today using the EQ-5D-5L: Protocol of a mixed-methods study. Frontiers in Public Health. 11:1031978. 2023
- Uniform regularity estimates and inviscid limit for the compressible non-resistive magnetohydrodynamics system. Nonlinearity. 36:354-400. 2023
- VANISHING VISCOSITY LIMIT FOR COMPRESSIBLE MAGNETOHYDRODYNAMIC EQUATIONS WITH TRANSVERSE BACKGROUND MAGNETIC FIELD. Communications in Mathematical Sciences. 21:1363-1392. 2023
- Correction: Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care. Trials. 23:547. 2022
- EE528 Resource Use and Costs Associated With Computerized Decision Support System for Managing Patients With Atrial Fibrillation. Value in Health. 25:S159-S160. 2022
- Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis. Canadian Journal of Anaesthesia. 69:1515-1526. 2022
- OP070 [Critical Care Rehabilitation » Rehabilitation]: EARLY REHABILITATION IN CRITICALLY ILL CHILDREN – A MULTI-SITE IMPLEMENTATION STUDY. Pediatric Critical Care Medicine. 23. 2022
- Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia. Health and Quality of Life Outcomes. 20:140. 2022
- Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review. BMC Pregnancy and Childbirth. 22:747. 2022
- China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population. PharmacoEconomics (Auckland). 40:957-969. 2022
- Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC). Clinical Genitourinary Cancer. 20:e353-e361. 2022
- Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention. Circulation. Genomic and precision medicine. 15:e003423. 2022
- How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China. Value in Health. 25:1768-1777. 2022
- Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline. Journal of Evidence-Based Medicine. 15:263-271. 2022
- How Do Health Schemas Inform Healthy Behaviours During Pregnancy? Qualitative Findings from the Be Healthy in Pregnancy (BHIP) Study. Maternal and Child Health Journal. 26:1861-1870. 2022
- Psychometric Evaluation of the Mandarin HeartQoL Health-Related Quality of Life Questionnaire Among Patients With Ischemic Heart Disease in China.. Value in Health Regional Issues. 31:53-60. 2022
- Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review. Journal of Clinical Epidemiology. 148:81-92. 2022
- Health-related quality-of-life and health-utility reporting in critical care. World Journal of Critical Care Medicine. 11:236-245. 2022
- A Systematic Literature Review of Health Utility Values in Breast Cancer. Medical decision making. 42:704-719. 2022
- EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors. Value in Health. 25:S428-S428. 2022
- Population Norms for SF-6Dv2 and EQ-5D-5L in China. Applied Health Economics and Health Policy. 20:573-585. 2022
- Routine systematic sampling versus targeted sampling during endobronchial ultrasound: A randomized feasibility trial. Journal of Thoracic and Cardiovascular Surgery. 164:254-261.e1. 2022
- Industry sponsorship bias in cost effectiveness analysis: registry based analysis. The BMJ. 377:e069573-e069573. 2022
- Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naïve, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.. Journal of Clinical Oncology. 40:e19062-e19062. 2022
- Rhythm Control Vs Rate Control in a Contemporary Ambulatory Atrial Fibrillation Cohort: Post Hoc Analysis of the IMPACT-AF Trial. CJC OPEN. 4:551-557. 2022
- Time-Specific Differences in Stated Preferences for Health in the United States. Medical Care. 60:462-469. 2022
- Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.. Journal of Clinical Oncology. 40:e19020-e19020. 2022
- Responsiveness of the HUG-5 in an outpatient clinic: a 12-month randomised feasibility study protocol. BMJ Open. 12:e061057-e061057. 2022
- Transforming challenges into opportunities: conducting health preference research during the COVID-19 pandemic and beyond. Quality of Life Research. 31:1191-1198. 2022
- Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD). BMJ Open. 12:e053246-e053246. 2022
- Fighting COVID-19: a qualitative study into the lives of intensive care unit survivors in Wuhan, China. BMJ Open. 12:e055365-e055365. 2022
- Methodologic and Reporting Quality of Economic Evaluations in Hand and Wrist Surgery: A Systematic Review. Plastic and Reconstructive Surgery. 149:453e-464e. 2022
- Be Healthy in Pregnancy (BHIP): A Randomized Controlled Trial of Nutrition and Exercise Intervention from Early Pregnancy to Achieve Recommended Gestational Weight Gain. Nutrients. 14:810-810. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents. Journal of Clinical Epidemiology. 142:133-143. 2022
- What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks. Value in Health. 25:302-317. 2022
- A look back at the first wave of COVID-19 in China: A systematic review and meta-analysis of mortality and health care resource use among severe or critical patients. PLoS ONE. 17:e0265117-e0265117. 2022
- More work needed on decision analysis for shared decision-making: A scoping review. Journal of Clinical Epidemiology. 141:106-120. 2022
- RAVAL trial: Protocol of an international, multi-centered, blinded, randomized controlled trial comparing robotic-assisted versus video-assisted lobectomy for early-stage lung cancer. PLoS ONE. 17:e0261767-e0261767. 2022
- A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. Journal of Clinical Epidemiology. 140:69-78. 2021
- An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMC Women's Health. 21:8. 2021
- Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care. Trials. 22:531. 2021
- Temporal Trends and Factors Associated With the Inclusion of Patient‐Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review. Journal of the American Heart Association. 10:e022353. 2021
- Educating Outpatients for Bowel Preparation Before Colonoscopy Using Conventional Methods vs Virtual Reality Videos Plus Conventional Methods. JAMA network open. 4:e2135576-e2135576. 2021
- Global solvability of 2D MHD boundary layer equations in analytic function spaces. Journal of Differential Equations. 299:362-401. 2021
- Temporal trends in the inclusion of patient-reported outcomes in heart failure randomized trials published in high-impact medical journals: a systematic bibliometric review. European Heart Journal. 42:ehab724.3171. 2021
- Quantifying the impacts of human mobility restriction on the spread of coronavirus disease 2019: an empirical analysis from 344 cities of China. National Medical Journal of China. 134:2438-2446. 2021
- Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. JAMA network open. 4:e2122079-e2122079. 2021
- Effect of patient‐centered transitional care services on patient‐reported outcomes in heart failure: sex‐specific analysis of the PACT‐HF randomized controlled trial. European Journal of Heart Failure. 23:1488-1498. 2021
- Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT). PharmacoEconomics (Auckland). 39:1075-1084. 2021
- Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. Journal of Alzheimer's Disease. 83:77-87. 2021
- Patient‐Reported Outcomes and Patient‐Reported Experience of Patients With Atrial Fibrillation in the IMPACT‐AF Clinical Trial. Journal of the American Heart Association. 10:e019783. 2021
- Guidelines that use the GRADE approach often fail to provide complete economic information for recommendations: A systematic survey. Journal of Clinical Epidemiology. 136:203-215. 2021
- Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease. Medical decision making. 41:685-692. 2021
- Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. European Journal of Health Economics. 22:723-733. 2021
- HT3 What is Value? A Systematic Review of Value Assessment Frameworks. Value in Health. 24:S9-S9. 2021
- A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L. Journal of General Internal Medicine. 36:1292-1301. 2021
- Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review*. Critical Care Medicine. 49:575-588. 2021
- Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 11:e046021-e046021. 2021
- Economic Analysis of Mobile Integrated Health Care Delivered by Emergency Medical Services Paramedic Teams. JAMA network open. 4:e210055-e210055. 2021
- Be Healthy in Pregnancy: Exploring factors that impact pregnant women's nutrition and exercise behaviours. Maternal and Child Nutrition. 17:e13068. 2021
- Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia. Saudi Journal of Gastroenterology. 27:208-208. 2021
- Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China. Patient Preference and Adherence. Volume 15:775-783. 2021
- GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making. Journal of Clinical Epidemiology. 129:138-150. 2021
- VERIFICATION OF PRANDTL BOUNDARY LAYER ANSATZ FOR STEADY ELECTRICALLY CONDUCTING FLUIDS WITH A MOVING PHYSICAL BOUNDARY. SIAM Journal on Mathematical Analysis. 53:4997-5059. 2021
- A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial. Trials. 21:771. 2020
- Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial. Pilot and Feasibility Studies. 6:61. 2020
- 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set. Quality of Life Research. 29:3109-3118. 2020
- Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study. Plastic and Reconstructive Surgery - Global Open. 8:e3179-e3179. 2020
- Cost-effectiveness Analysis of Abdominal-based Autogenous Tissue and Tissue-expander Implant following Mastectomy. Plastic and Reconstructive Surgery - Global Open. 8:e2986-e2986. 2020
- Identifying factors associated with high use of acute care in Canada: protocol of a population-based retrospective cohort study. BMJ Open. 10:e038008-e038008. 2020
- Association of Roux-en-Y Gastric Bypass With Postoperative Health Care Use and Expenditures in Canada. JAMA Surgery. 155:e201985-e201985. 2020
- Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells.. Aging. 12:15546-15555. 2020
- Economic evaluation of robot-assisted radical prostatectomy compared to open radical prostatectomy for prostate cancer treatment in Ontario, Canada. Journal of the Canadian Urological Association. 14:E350-E357. 2020
- Quantifying the impacts of human mobility restriction on the spread of COVID-19: an empirical analysis from 344 cities of China 2020
- Darboux polynomials and rational first integrals of the nonstretching Rolie-Poly model. Applied Mathematics Letters. 105. 2020
- Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials. European Journal of Health Economics. 21:717-728. 2020
- Acceptability and Validity of the EQ-5D in Patients Living With Dementia. Value in Health. 23:760-767. 2020
- Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol. BMJ Open. 10:e036047-e036047. 2020
- Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool. American Heart Journal. 224:35-46. 2020
- The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound. Journal of Thoracic and Cardiovascular Surgery. 159:2499-2507.e3. 2020
- Abstract 290: Lessons Learned From Integrated Management Program Advancing Community Treatment Of Atrial Fibrillation (IMPACT-AF): A Pragmatic Clinical Trial Of Computerized Decision Support In Primary Healthcare. Circulation. Cardiovascular Quality and Outcomes. 13. 2020
- PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT). Value in Health. 23:S286-S287. 2020
- Using Both Time Tradeoff and Discrete Choice Experiments in Valuing the EQ-5D: Impact of Model Misspecification on Value Sets. Medical decision making. 40:483-497. 2020
- Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis. Journal of Alzheimer's Disease. 74:449-462. 2020
- An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta. Healthcare Policy. 15:90-101. 2020
- Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults. Hypertension. 75:339-346. 2020
- Probiotics in hospitalized adult patients: a systematic review of economic evaluations. Canadian Journal of Anaesthesia. 67:247-261. 2020
- Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines. Journal of Population Therapeutics and Clinical Pharmacology. 27:e1-e24. 2020
- International phase 1 study protocol to develop a health state classification system for a preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMJ Open. 10:e034451-e034451. 2020
- Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis. EClinicalMedicine. 18:100237-100237. 2020
- Asymptotic limits of the isentropic compressible viscous magnetohydrodynamic equations with Navier-slip boundary conditions. Journal of Differential Equations. 267:6910-6957. 2019
- A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. PharmacoEconomics - Open. 3:437-451. 2019
- Experiences regarding nutrition and exercise among women during early postpartum: a qualitative grounded theory study. BMC Pregnancy and Childbirth. 19:368. 2019
- Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China. Clinical Therapeutics. 41:2308-2320.e11. 2019
- Cost‐effectiveness of a collaborative dementia care management—Results of a cluster‐randomized controlled trial. Alzheimer's and Dementia. 15:1296-1308. 2019
- Educational virtual reality videos in improving bowel preparation quality and satisfaction of outpatients undergoing colonoscopy: protocol of a randomised controlled trial. BMJ Open. 9:e029483-e029483. 2019
- United States Valuation of EQ-5D-5L Health States Using an International Protocol. Value in Health. 22:931-941. 2019
- Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation. Journal of Glaucoma. 28:593-600. 2019
- Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer. MDM Policy and Practice. 4:238146831985259-238146831985259. 2019
- O5‐08‐06: COST‐EFFECTIVENESS OF A COLLABORATIVE DEMENTIA CARE MANAGEMENT – RESULTS OF A CLUSTER‐RANDOMIZED CONTROLLED TRIAL. Alzheimer's and Dementia. 15:p1637-p1637. 2019
- Latent Class Models Reveal Poor Agreement between Discrete-Choice and Time Tradeoff Preferences. Medical decision making. 39:421-436. 2019
- Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB). Medical decision making. 39:371-379. 2019
- Canada’s Amendment to Patented Drug Price Regulation. Journal of the American Medical Association (JAMA). 321:1565-1565. 2019
- Abstract 198: Lifetime Clinical Benefit of Folic Acid Therapy for Primary Prevention of Stroke in Patients with Hypertension - Projection Based on the CSPPT. Circulation. Cardiovascular Quality and Outcomes. 12. 2019
- How do financial (dis)incentives influence health behaviour and costs? Protocol for a systematic literature review of randomised controlled trials. BMJ Open. 9:e024694-e024694. 2019
- Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer. Oncologist. 24:349-357. 2019
- Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma. Cancer Treatment Reviews. 74:43-48. 2019
- Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure. Journal of the American Medical Association (JAMA). 321:753-753. 2019
- JUSTIFICATION OF PRANDTL ANSATZ FOR MHD BOUNDARY LAYER. SIAM Journal on Mathematical Analysis. 51:2748-2791. 2019
- Patient Experiences and Opinions of a Behavioral Activation Group Intervention for Depression. Research on Social Work Practice. 29:10-18. 2019
- Enhancing the Participation of Older Adults With Subjective Cognitive Decline Using Tele-Rehabilitation. Archives of Physical Medicine and Rehabilitation. 99:e198-e199. 2018
- Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology. JAMA Internal Medicine. 178:1586-1586. 2018
- FIT for FUNCTION: study protocol for a randomized controlled trial. Trials. 19:39. 2018
- Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL). Health and Quality of Life Outcomes. 16:78. 2018
- Structured diet and exercise guidance in pregnancy to improve health in women and their offspring: study protocol for the Be Healthy in Pregnancy (BHIP) randomized controlled trial. Trials. 19:691. 2018
- A note on the ill-posedness of shear flow for the MHD boundary layer equations. Science China Mathematics. 61:2065-2078. 2018
- Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community‐based survey in China. Diabetes/Metabolism Research and Reviews. 34:e3053. 2018
- Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets. Medical decision making. 38:968-982. 2018
- Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand. PharmacoEconomics - Open. 2:297-308. 2018
- Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand. PharmacoEconomics - Open. 2:281-296. 2018
- Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation. PharmacoEconomics (Auckland). 36:883-888. 2018
- Multimedia Appendix Correction: A Computer-Assisted Personal Interview App in Research Electronic Data Capture for Administering Time Trade-off Surveys (REDCap): Development and Pretest. JMIR Formative Research. 2:e11436-e11436. 2018
- Optimizing primary care management of atrial fibrillation: The rationale and methods of the Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) study. American Heart Journal. 201:149-157. 2018
- P4‐165: COST‐UTILITY ANALYSIS OF DEMENTIA CARE MANAGEMENT: RESULTS OF THE CLUSTER‐RANDOMIZED, CONTROLLED, INTERVENTIONAL TRIAL DELPHI‐MV. Alzheimer's and Dementia. 14:p1502-p1503. 2018
- Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma. Journal of Glaucoma. 27:585-591. 2018
- Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial. American Heart Journal. 199:75-82. 2018
- Robotic Versus Video-Assisted Thoracoscopic Lung Resection During Early Program Development. Annals of Thoracic Surgery. 105:1050-1057. 2018
- Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada. PharmacoEconomics - Open. 2:19-29. 2018
- Decay rates of solutions to a P1-approximation model arising from radiation hydrodynamics. Journal of Differential Equations. 264:2936-2969. 2018
- Transforming Latent Utilities to Health Utilities: East Does Not Meet West (vol 26, pg 1524, 2017). Health Economics. 27:E181-E181. 2018
- A Computer-Assisted Personal Interview App in Research Electronic Data Capture for Administering Time Trade-off Surveys (REDCap): Development and Pretest. JMIR Formative Research. 2:e3-e3. 2018
- A limit problem for three-dimensional ideal compressible radiation magneto-hydrodynamics. Analysis and Applications. 16:85-102. 2018
- A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. ClinicoEconomics and Outcomes Research. Volume 10:821-854. 2018
- Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size. Medical decision making. 38:26-33. 2018
- GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains. Journal of Clinical Epidemiology. 111:83-93. 2018
- PP51 Updating Canadian Pharmaceutical Budget Impact Analysis Guidelines. International Journal of Technology Assessment in Health Care. 34:86-86. 2018
- Feasibility of an altruistic sperm donation program in Canada: results from a population-based model. Reproductive Health. 14:8. 2017
- Transforming Latent Utilities to Health Utilities: East Does Not Meet West. Health Economics. 26:1524-1533. 2017
- Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 6:e228-e228. 2017
- Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale. European Journal of Health Economics. 18:967-977. 2017
- A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors. Human Vaccines and Immunotherapeutics. 13:1765-1767. 2017
- Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Quality of Life Research. 26:2057-2066. 2017
- Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 26:1483-1492. 2017
- Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies. Journal of Clinical Epidemiology. 85:21-31. 2017
- Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status. Obesity Surgery. 27:1128-1128. 2017
- Handling Regional Variation in Health State Preferences within a Country. Medical decision making. 37:252-261. 2017
- Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value in Health. 20:644-650. 2017
- Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value in Health. 20:644-650. 2017
- Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments. Medical decision making. 37:262-272. 2017
- Systemic Therapy for Previously Untreated Advanced BRAF -Mutated Melanoma: Navigating a Shifting Landscape. Immunotherapy. 9:375-378. 2017
- Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma. JAMA Oncology. 3:366-366. 2017
- Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers. Clinical Chemistry. 63:593-602. 2017
- The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status. Obesity Surgery. 27:349-356. 2017
- Acknowledgement of manuscript reviewers 2015. Health and Quality of Life Outcomes. 14:29. 2016
- Behavioral activation group therapy for reducing depressive symptoms and improving quality of life: a feasibility study. Pilot and Feasibility Studies. 2:22. 2016
- Can the general public use vignettes to discriminate between Alzheimer’s disease health states?. BMC Geriatrics. 16:36. 2016
- EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada. Quality of Life Research. 25:3009-3016. 2016
- Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies. PharmacoEconomics (Auckland). 34:1087-1100. 2016
- Preference-based disease-specific health-related quality of life instrument for glaucoma: a mixed methods study protocol. BMJ Open. 6:e012732-e012732. 2016
- ON THE RAYLEIGH-TAYLOR INSTABILITY FOR THE COMPRESSIBLE NON-ISENTROPIC INVISCID FLUIDS WITH A FREE INTERFACE. Discrete and Continuous Dynamical Systems - Series B. 21:2767-2784. 2016
- Singularly perturbed semilinear elliptic boundary value problems with discontinuous source term. Boundary Value Problems. 2016. 2016
- Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol. BMJ Open. 6:e012909-e012909. 2016
- How different are composite and traditional TTO valuations of severe EQ-5D-5L states?. Quality of Life Research. 25:2101-2108. 2016
- Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 25:1679-1685. 2016
- Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Quality of Life Research. 25:979-986. 2016
- Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility. Medical decision making. 36:223-233. 2016
- A Geometric Approach to Stationary Defect Solutions in one Space Dimension. SIAM Journal on Applied Dynamical Systems. 15:655-712. 2016
- A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada. Medical Care. 54:98-105. 2016
- Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study. PLoS ONE. 11:e0162422-e0162422. 2016
- How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations. Quality of Life Research. 25:35-43. 2016
- A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol. Pilot and Feasibility Studies. 1:39. 2015
- Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?. European Journal of Health Economics. 16:847-855. 2015
- Patient-reported health preferences of anticoagulant-related outcomes. Journal of Thrombosis and Thrombolysis. 40:268-273. 2015
- A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). PharmacoEconomics (Auckland). 33:867-877. 2015
- Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 33:2296-2302. 2015
- Zero dissipation limit and stability of boundary layers for the heat conductive Boussinesq equations in a bounded domain. Proceedings of the Royal Society of Edinburgh Section A: Mathematics. 145:611-637. 2015
- The economics of adalimumab for ulcerative colitis. Expert Review of Pharmacoeconomics and Outcomes Research. 15:373-377. 2015
- Singularly perturbed second order semilinear boundary value problems with interface conditions. Boundary Value Problems. 2015. 2015
- LOCAL WELL-POSEDNESS OF PRANDTL EQUATIONS FOR COMPRESSIBLE FLOW IN TWO SPACE VARIABLES. SIAM Journal on Mathematical Analysis. 47:321-346. 2015
- NONRELATIVISTIC LIMIT OF THE COMPRESSIBLE NAVIER-STOKES-FOURIER-P1 APPROXIMATION MODEL ARISING IN RADIATION HYDRODYNAMICS. SIAM Journal on Mathematical Analysis. 47:3726-3746. 2015
- Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation. Cardiovascular Drugs and Therapy. 28:575-585. 2014
- Expression of epithelial cell adhesion molecule associated with elevated ductular reactions in hepatocellar carcinoma.. Clinics and Research in Hepatology and Gastroenterology. 38:699-705. 2014
- Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China. Value in Health. 17:A782-A782. 2014
- Impact of Demographics on Health Preferences in China: An Exploratory Analysis of China EQ-5D-5L Valuation Study. Value in Health. 17:A753-A753. 2014
- Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values. Medical Care. 52:935-943. 2014
- An interface problem with singular perturbation on a subinterval. Boundary Value Problems. 2014. 2014
- [Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration].. Chinese Journal of Ophthalmology. 50:426-433. 2014
- Assessment of Preference for Hormonal Treatment–Related Health States among Patients with Breast Cancer. Value in Health Regional Issues. 3:27-32. 2014
- Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best–worst scaling?. European Journal of Health Economics. 15:281-288. 2014
- Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study. Hospital Practice. 42:38-45. 2014
- Comparing EQ-5D Valuation Studies. Medical decision making. 34:8-20. 2014
- A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine. 5:205ra134. 2013
- HYPERBOLIC-HYPERBOLIC RELAXATION LIMIT FOR A 1D COMPRESSIBLE RADIATION HYDRODYNAMICS MODEL: SUPERPOSITION OF RAREFACTION AND CONTACT WAVES. Communications on Pure and Applied Analysis. 12:2145-2171. 2013
- Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. Journal of Thoracic and Cardiovascular Surgery. 146:52-60.e3. 2013
- Model-based economic evaluation for medical decision making: learn from the past and prepare for the future.. Journal of Thoracic Disease. 5:209-210. 2013
- Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis. PharmacoEconomics (Auckland). 31:501-508. 2013
- Cost-Effectiveness of Pharmaceutical Management for Osteoarthritis Pain. Drugs and Aging. 30:277-284. 2013
- Health utilities index®: Extending the age range to pre-schoolers. Value in Health. 16:A35-A36. 2013
- PRM174 Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Value in Health. 16:a44-a45. 2013
- Scoring the 5-Level EQ-5D. Medical decision making. 33:567-578. 2013
- Conceptual Framework for Health‐related Quality of Life Assessment in Acute Gastroenteritis. Journal of Pediatric Gastroenterology and Nutrition. 56:280-289. 2013
- Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?. European Urology. 63:411-412. 2013
- Reply to the Editor. Journal of Thoracic and Cardiovascular Surgery. 145:608-609. 2013
- A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Journal of the Canadian Urological Association. 7:335-335. 2013
- Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation. International Journal of Vascular Medicine. 2013:1-11. 2013
- Photoselective vaporization for the treatment of benign prostatic hyperplasia.. Ontario Health Technology Assessment Series. 13:1-34. 2013
- The excess burden of rheumatoid arthritis in Ontario, Canada.. Clinical and Experimental Rheumatology. 31:18-24. 2013
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update.. Ontario Health Technology Assessment Series. 13:1-40. 2013
- Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. Journal of Interventional Cardiac Electrophysiology. 35:259-275. 2012
- Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review. Genetic Testing and Molecular Biomarkers. 16:1322-1335. 2012
- PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada. Value in Health. 15:A495-A496. 2012
- Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada. Value in Health. 15:894-906. 2012
- Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore. Value in Health Regional Issues. 1:46-53. 2012
- Health State Utility Assessment for Breast Cancer. Value in Health Regional Issues. 1:93-97. 2012
- Measuring health-related quality-of-life for Alzheimer’s disease using the general public. Quality of Life Research. 21:593-601. 2012
- NONLINEAR STABILITY OF COMBINATION OF VISCOUS CONTACT WAVE WITH RAREFACTION WAVES FOR A 1D RADIATION HYDRODYNAMICS MODEL. Discrete and Continuous Dynamical Systems - Series B. 17:1075-1100. 2012
- Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study. Hospital Practice. 40:131-137. 2012
- The excess burden of osteoarthritis in the province of Ontario, Canada. Arthritis and Rheumatism. 64:1153-1161. 2012
- Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 138:455-462. 2012
- Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease. Journal of Crohn's and Colitis. 6:77-85. 2012
- On a class of singular boundary value problems with singular perturbation. Journal of Differential Equations. 252:2370-2387. 2012
- An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore. Value in Health. 15:S72-S78. 2012
- Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e166-e178. 2012
- Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. ClinicoEconomics and Outcomes Research. 4:287-287. 2012
- Discussing study limitations in reports of biomedical studies-the need for more transparency. Health and Quality of Life Outcomes. 10:23-23. 2012
- Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. ClinicoEconomics and Outcomes Research. 4:21-21. 2012
- Oral S-1/Leucovorin combination in treatment of patient with an advanced large primary hepatocellular carcinoma. Life Science Journal. 9:1353-1355. 2012
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B).. Ontario Health Technology Assessment Series. 12:1-62. 2012
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskeletal Disorders. 12:209. 2011
- Calculating Utility Decrements Associated With an Adverse Event. Medical decision making. 31:790-799. 2011
- Calculating Utility Decrements Associated With an Adverse Event: Marginal Tobit and CLAD Coefficients Should Be Used With Caution. Medical decision making. 31:790-799. 2011
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis. Seminars in Arthritis and Rheumatism. 41:178-186. 2011
- Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Review of Pharmacoeconomics and Outcomes Research. 11:513-521. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources.. International Journal of Circumpolar Health. 70:417-427. 2011
- Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Quality of Life Research. 20:939-943. 2011
- Ontario Multidetector Computed Tomographic Coronary Angiography Study. JAMA Internal Medicine. 171:1021-1029. 2011
- Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index (vol 13, pg 873, 2010). Value in Health. 14:620-620. 2011
- Triple Therapy for the Management of COPD: A Review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 8:206-243. 2011
- Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis. International Journal of Rheumatic Diseases. 14:206-210. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources. International Journal of Circumpolar Health. 70:419-427. 2011
- Disturbed solution of the El Nino-southern oscillation sea-air delayed oscillator. Wuli Xuebao/Acta Physica Sinica. 20. 2011
- Existence of Solutions for Fractional Differential Equations with Multi-point Boundary Conditions at Resonance on a Half-line. Electronic Journal of Qualitative Theory of Differential Equations. 1-16. 2011
- SINGULAR LIMIT TO STRONG CONTACT DISCONTINUITY FOR A 1D COMPRESSIBLE RADIATION HYDRODYNAMICS MODEL. SIAM Journal on Mathematical Analysis. 43:1189-1204. 2011
- Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada. International Journal of Vascular Medicine. 2011:1-10. 2011
- The solutions for disturbed El Nino/La Nina-southern oscillation model. Wuli Xuebao/Acta Physica Sinica. 60. 2011
- Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. ClinicoEconomics and Outcomes Research. 3:89-89. 2011
- Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health and Quality of Life Outcomes. 8:116. 2010
- Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index. Value in Health. 13:873-878. 2010
- General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals. Expert Review of Pharmacoeconomics and Outcomes Research. 10:379-384. 2010
- Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?. Value in Health. 13:487-494. 2010
- Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario. Value in Health. 13:S8-S11. 2010
- PMS58 HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. 13:A133-A133. 2010
- PMS60 UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO. Value in Health. 13:A133-A134. 2010
- A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment. PharmacoEconomics (Auckland). 28:255-277. 2010
- Patient outcomes after anti TNF-α drugs for Crohn’s disease. Expert Review of Pharmacoeconomics and Outcomes Research. 10:163-175. 2010
- Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.. World Journal of Gastroenterology. 16:1123-1128. 2010
- Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. European Journal of Health Economics. 11:27-34. 2010
- Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.. Open Medicine. 4:e154-e166. 2010
- A review of health utilities across conditions common in paediatric and adult populations. Health and Quality of Life Outcomes. 8:12-12. 2010
- Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation. 8:14-14. 2010
- Evaluation of health outcomes in osteoarthritis patients after total knee replacement: a two-year follow-up. Health and Quality of Life Outcomes. 8:87-87. 2010
- On the Step-type Contrast Structure of a Second-order Semilinear Differential Equation with Integral Boundary Conditions. Electronic Journal of Qualitative Theory of Differential Equations. 1-14. 2010
- Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.. World Journal of Gastroenterology. 15:5976-5982. 2009
- Asymptotic solution of the van der Pol oscillator with small fractional damping. Physica Scripta. T136. 2009
- GLOBAL WEAK SOLUTIONS OF AN INITIAL BOUNDARY VALUE PROBLEM FOR SCREW PINCHES IN PLASMA PHYSICS. Mathematical Models and Methods in Applied Sciences. 19:833-875. 2009
- Approaches for Economic Evaluations of Health Care Technologies. Journal of the American College of Radiology. 6:307-316. 2009
- Conditionally Funded Field Evaluations and Practical Trial Design Within a Health Technology Assessment Framework. Journal of the American College of Radiology. 6:324-331. 2009
- Existence of Canards under Non-generic Conditions. Chinese Annals of Mathematics. Series B. 30:239-250. 2009
- Health Technology Assessment and Primary Data Collection for Reducing Uncertainty in Decision Making. Journal of the American College of Radiology. 6:332-342. 2009
- Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada. Journal of the American College of Radiology. 6:317-323. 2009
- Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. Clinical Therapeutics. 31:1082-1091. 2009
- In search of the evidentiary foundation of published Canadian economic evaluations (2001–06). International Journal of Technology Assessment in Health Care. 25:214-221. 2009
- A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada. Value in Health. 12:245-252. 2009
- Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder. International Journal of Psychiatry in Clinical Practice. 13:59-69. 2009
- Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis. Cost Effectiveness and Resource Allocation. 7:20-20. 2009
- Excess Risk of Mortality and Complications Associated with Newly Diagnosed Cases of Diabetes in Ontario, Canada. Canadian Journal of Diabetes. 33:93-104. 2009
- Prevalence, Total and Excess Costs of Diabetes and Related Complications in Ontario, Canada. Canadian Journal of Diabetes. 33:35-45. 2009
- Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?. International Journal of Technology Assessment in Health Care. 24:437-444. 2008
- The need for standardization: A literature review of indirect costs of rheumatoid arthritis and osteoarthritis. Arthritis and Rheumatism. 59:1027-1033. 2008
- Cost effectiveness analysis of population-based serology screening and ¹³C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model. World Journal of Gastroenterology. 14:3021-3027. 2008
- Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Quality of Life Research. 17:595-601. 2008
- A novel method for a class of parameterized singularly perturbed boundary value problems. Journal of Computational and Applied Mathematics. 213:258-267. 2008
- A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore. Value in Health. 11:S84-S90. 2008
- Applying the Expectancy-Value Model to Understand Health Values. Value in Health. 11:S61-S68. 2008
- Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore. Value in Health. 11:S3-S10. 2008
- Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore. Quality of Life Research. 17:115-122. 2008
- Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. International Journal of Technology Assessment in Health Care. 24:87-95. 2008
- GL method for solving equations in math-physics and engineering. Acta Mathematicae Applicatae Sinica. 24:391-404. 2008
- Global existence and asymptotic behavior of weak solutions to the 1D compressible Navier-Stokes equations with degenerate viscosity coefficient. Asymptotic Analysis. 60:101-123. 2008
- Validation of the International Classification of Functioning, Disability, and Health (ICF) Brief Core Set for osteoarthritis. Scandinavian Journal of Rheumatology. 37:450-461. 2008
- Validation of the Comprehensive ICF Core Set for Osteoarthritis (OA) in patients with knee OA: a Singaporean perspective.. Journal of Rheumatology. 34:2301-2307. 2007
- Canards in a rheodynamic model of cardiac pressure pulsations. Wuli Xuebao/Acta Physica Sinica. 16:2635-2639. 2007
- Cross-cultural adaptation and validation of Singapore English and Chinese Versions of the Oxford Knee Score (OKS) in knee osteoarthritis patients undergoing total knee replacement.. Osteoarthritis and Cartilage. 15:1019-1024. 2007
- Cross-cultural adaptation and validation of Singapore English and Chinese versions of the Lequesne Algofunctional Index of knee in Asians with knee osteoarthritis in Singapore.. Osteoarthritis and Cartilage. 15:19-26. 2007
- Direct and indirect costs of OA in Singapore: A comparative study among multiethnic Asian patients. Journal of Rheumatology. 34:165-171. 2007
- Are Asians comfortable with discussing death in health valuation studies? A study in multi-ethnic Singapore. Health and Quality of Life Outcomes. 4:93. 2006
- Cross-cultural adaptation and validation of Singapore English and Chinese versions of the Knee injury and Osteoarthritis Outcome Score (KOOS) in Asians with knee osteoarthritis in Singapore.. Osteoarthritis and Cartilage. 14:1098-1103. 2006
- Are they relevant? A critical evaluation of the international classification of functioning, disability, and health core sets for osteoarthritis from the perspective of patients with knee osteoarthritis in Singapore.. Annals of the Rheumatic Diseases. 65:1067-1073. 2006
- Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore. Human Psychopharmacology. 20:459-465. 2005
- Do health-related quality-of-life domains and items in knee and hip osteoarthritis vary in importance across social-cultural contexts? A qualitative systematic literature review.. Seminars in Arthritis and Rheumatism. 34:793-804. 2005
- The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore. Quality of Life Research. 14:1181-1186. 2005
- Intraductal Papillary Mucinous Neoplasms of the Pancreas - Predictors of Malignancy. Hepato-Gastroenterology: current medical and surgical trends. 57:635-639.
- P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. HemaSphere. 6:451-452.
- P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. HemaSphere. 6:669-670.
preprints